Abbott P/B Ratio
Abbott (ABBOTINDIA) P/B ratio is 13.47 (High), book value per share ₹2015.71 vs Healthcare average P/B of -1.0 — Very High - Significant premium, high growth expectations or speculative. For live price, earnings yield and the full fundamental profile, see ABBOTINDIA company profile.
Current Valuation Metrics
Book Value Breakdown (2025)
Valuation Signal
Sector Context
ABBOTINDIA P/B Ratio — Valuation Insights & Book Value Analysis
Abbott price-to-book ratio interpretation, valuation status and historical context — current P/B 13.47 (High).
- Stock appears overvalued with PB of 13.47, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Trading at premium to sector average PB of -1.0
Abbott P/B Ratio Historical Trend
ABBOTINDIA annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Browse ABBOTINDIA balance sheet details for revenue, profit, balance sheet and cash flow data.
ABBOTINDIA Historical P/B Ratio — Book Value Per Share & Year-End Price
Abbott annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2025 | 14.4 | ₹2015.71 | ₹29025.00 | ₹4,233 | High |
| 2024 | 16.88 | ₹1761.43 | ₹29741.00 | ₹3,699 | High |
| 2023 | 15.05 | ₹1518.57 | ₹22851.25 | ₹3,189 | High |
| 2022 | 15.91 | ₹1342.86 | ₹21367.20 | ₹2,820 | High |
| 2021 | 15.73 | ₹1239.05 | ₹19485.65 | ₹2,602 | High |
ABBOTINDIA vs Healthcare Peers — P/B Ratio Comparison
Abbott P/B 13.47 vs Healthcare average -1.0, median 0.62 — range -36.63–1.05.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -36.63 | ₹28 | Low |
| Sun Pharma Advanced Rese… | SPARC | -13.83 | ₹4,744 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.35 | ₹76 | Low |
| Parmax Pharma | PARMAX | -2.09 | ₹12 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.8 | ₹128 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |